The Research Programme on Biomedical Informatics (GRIB) is a joint research group of IMIM-Hospital del Mar Research Institute and Universitat Pompeu Fabra (UPF). We carry out fundamental research and technological developments on the application of advanced information technologies and computational methods in the health and life sciences. GRIB brings together a multidisciplinary team of more than seventy scientists, as well as technical and management staff.

GRIB has a wide experience in the participation and coordination of research projects funded by the European Commission and other research funding agencies. GRIB has a long tradition of collaboration with the pharmaceutical  and biotechnological industry in the framework of R&D projects and also providing services especially in the development of computational methods for drug discovery. GRIB staff is involved in pre and postgraduate teaching at the UPF, with a particularly intense involvement in its Master degree in Bioinformatics in Health Sciences.

GRIB coordinates jointly with Farmaindustria the Plataforma Española de Medicamentos Innovadores (PTMI) and the Director of GRIB is one of the members of the Scientific Committee of the European Innovative Medicines Iniciative (IMI JTI). GRIB is recognized and funded by the Autonomous Government of Catalonia and one of the centres of TECNIO, the Catalan Technological Innovation Network created by ACC10 and is also the node for Biomedical Informatics of the Spanish Institute of Bioinformatics (INB).

We are located at Biomedical Research Park of Barcelona (PRBB) where an exceptional cluster of research programmes and groups are working on Computational Biology and Biomedical Informatics. The collaborations within scientists of these groups are frequent and productive, in particular between the Computational Genomics lab of GRIB and the Bioinformatics Programme of the CRG.

The research activity of GRIB has originated the creation of two spin-off companies: Pharmatools Interactive Services, promoted by Ferran Sanz, and Chemotargets, promoted by Jordi Mestres.